Stock CSL CSL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News CSL Limited

Equities

CSL

AU000000CSL8

Market Closed - Australian S.E.
Other stock markets
 02:10:50 2024-06-11 am EDT 		5-day change 1st Jan Change
286.3 AUD -0.93% Intraday chart for CSL Limited +1.52% -0.12%
May. 30 US nears deal to fund Moderna's bird flu vaccine trial, FT reports RE
May. 27 US, European nations consider vaccinating workers exposed to bird flu RE

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
US nears deal to fund Moderna's bird flu vaccine trial, FT reports
RE
US, European nations consider vaccinating workers exposed to bird flu
RE
Banks push Australia shares down; James Hardie dips to 5-month low
RE
Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics' COVID-19 Vaccine
CI
Australia shares retreat as banks, technology, healthcare stocks drag
RE
Australia shares jump as US inflation data reinforces rate-cut hopes
RE
Australian shares end flat as miners offset losses in banks, energy; US CPI on tap
RE
Australian shares gain on fresh Fed rate-cut hopes, on track for best week in 5
RE
Australian shares retreat as miners, banks drag; CBA down on lower profit
RE
Australia's CSL tests 'dynamic pricing' of donor blood amid cost surge
RE
Commodity stocks lift Australian shares; RBA decision on tap
RE
Australian shares rise on US rate cut hopes; RBA in focus
RE
Australian shares fall as miners and banks drag; Fed in focus
RE
CSL : Seqirus and ARS Pharma sign agreement to commercialise neffy™ (adrenaline nasal spray) in Australia and New Zealand
PU
Ars Pharmaceuticals, Inc. Enters Exclusive License and Distribution Agreement with CSL Seqirus for Commercialization of Neffy in Australia and New Zealand
CI
Australian shares rise on banks, IT boost; Fed policy meet on tap
RE
Australian shares tumble as miners, energy stocks fall; BHP Group tanks
RE
CSL Vifor and Travere Therapeutics Announces European Commission Approves FILSPARI® for the Treatment of IgA Nephropathy
CI
Australian shares climb on banks, energy boost; March-quarter CPI in focus
RE
Australian shares follow Wall Street higher, miners limit gains
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CSL Stock
  4. News CSL Limited